Tashiro H, Brenner MK. Immunotherapy against cancer-related viruses. Cell Res. 2017;27:59–73.
Article
CAS
Google Scholar
Tindle RW. Immune evasion in human papillomavirus-associated cervical cancer. Nat Rev Cancer. 2002;2:59–64.
Article
CAS
Google Scholar
Münger K, et al. Mechanisms of human papillomavirus-induced oncogenesis. J Virol. 2004;78:11451–60.
Article
Google Scholar
Taylor GS, Long HM, Brooks JM, Rickinson AB, Hislop AD. The immunology of Epstein-Barr virus–induced disease. Annu Rev Immunol. 2015;33:787–821.
Article
CAS
Google Scholar
Zsiros E, Tsuji T, Odunsi K. Adoptive T-cell therapy is a promising salvage approach for advanced or recurrent metastatic cervical cancer. J Clin Oncol. 2015;33:1521–3.
Article
Google Scholar
Lutzky VP, et al. Cytotoxic T cell adoptive immunotherapy as a treatment for nasopharyngeal carcinoma. Clin Vaccine Immunol. 2014;21:256–9.
Article
Google Scholar
Rosenberg SA, et al. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. N Engl J Med. 1988;319:1676–80.
Article
CAS
Google Scholar
Dudley ME, et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol. 2005;23:2346–57.
Article
CAS
Google Scholar
Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer. 2008;8:299–308.
Article
CAS
Google Scholar
Stevanović S, et al. Complete regression of metastatic cervical cancer after treatment with human papillomavirus–targeted tumor-infiltrating T cells. J Clin Oncol. 2015;33:1543.
Article
Google Scholar
Louis CU, et al. Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma. J Immunother. 2010;33:983–90.
Article
CAS
Google Scholar
Bollard CM, et al. Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins. J Clin Oncol. 2014;32:798–808.
Article
CAS
Google Scholar
Schmitt TM, Ragnarsson GB, Greenberg PD. T cell receptor gene therapy for cancer. Hum Gene Ther. 2009;20:1240–8.
Article
CAS
Google Scholar
Dudley ME, Wunderlich JR, Shelton TE, Even J, Rosenberg SA. Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients. J Immunother. 2003;26:332–42.
Article
Google Scholar
Tran KQ, et al. Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy. J Immunother. 2008;31:742–51.
Article
CAS
Google Scholar
Draper LM, et al. Targeting of HPV-16+ epithelial cancer cells by TCR gene engineered T cells directed against E6. Clin Cancer Res. 2015;21:4431–9.
Article
CAS
Google Scholar
Schumacher TN. T-cell-receptor gene therapy. Nat Rev Immunol. 2002;2:512–9.
Article
CAS
Google Scholar
Baker PE, GíLLÍS S, Smith KA. Monoclonal cytolytic T-cell lines. J Exp Med. 1979;149:273–8.
Article
CAS
Google Scholar
Mariotti, S. & Nisini, R. in T Cell Protocols. Methods in Molecular BiologyTM Vol. 514 (eds De Libero G.) 65–93 (Springer, 2009).
Bernhard, H., Schmidt, B., Busch, D. H. & Peschel, C. in Adoptive Immunotherapy: Methods and Protocols, Methods Molecular Medicine Vol. 109 (eds Hoffmann MW Ludewig B) 175–184 (Springer, 2006).
Dössinger G, et al. MHC multimer-guided and cell culture-independent isolation of functional T cell receptors from single cells facilitates TCR identification for immunotherapy. PLoS ONE. 2013;8:e61384.
Article
Google Scholar
Hu Z, et al. A cloning and expression system to probe T-cell receptor specificity and assess functional avidity to neoantigens. Blood. 2018;132:1911–21.
Article
CAS
Google Scholar
Segaliny AI, et al. Functional TCR T cell screening using single-cell droplet microfluidics. Lab Chip. 2018;18:3733–49.
Article
CAS
Google Scholar
Xi-zhi JG, et al. Rapid cloning, expression, and functional characterization of paired αβ and γδ T-cell receptor chains from single-cell analysis. Mol Ther Methods Clin Dev. 2016;3:15054.
Article
Google Scholar
Zhu Y, Machleder E, Chenchik A, Li R, Siebert P. Reverse transcriptase template switching: a SMARTTM approach for full-length cDNA library construction. Biotechniques. 2001;30:892–7.
Article
CAS
Google Scholar
Sebestyén Z, et al. Human TCR that incorporate CD3ζ induce highly preferred pairing between TCRα and β chains following gene transfer. J Immunol. 2008;180:7736–46.
Article
Google Scholar
Govers C, Sebestyén Z, Coccoris M, Willemsen RA, Debets R. T cell receptor gene therapy: strategies for optimizing transgenic TCR pairing. Trends Mol Med. 2010;16:77–87.
Article
CAS
Google Scholar
Jin BY, et al. Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model. JCI Insight. 2018;3:e99488.
Article
Google Scholar
Thomas S, et al. Targeting the Wilms tumor antigen 1 by TCR gene transfer: TCR variants improve tetramer binding but not the function of gene modified human T cells. J Immunol. 2007;179:5803–10.
Article
CAS
Google Scholar
Lucas KG, Bao L, Bruggeman R, Dunham K, Specht C. The detection of CMV pp65 and IE1 in glioblastoma multiforme. J Neurooncol. 2011;103:231–8.
Article
CAS
Google Scholar
Nair SK, et al. Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells. Clin Cancer Res. 2014;20:2684–94.
Article
CAS
Google Scholar
Watanabe K, Goodrich J, Li C, Agha M, Greenberg P. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science. 1992;257:238–41.
Article
Google Scholar
Inderberg EM, Wälchli S. Long-term surviving cancer patients as a source of therapeutic TCR. Cancer Immunol Immunother. 2020;69:859–65.
Article
Google Scholar
Kamphorst AO, et al. Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients. Proc Natl Acad Sci U S A. 2017;114:4993–8.
Article
CAS
Google Scholar
Plon SE, et al. Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate. N Engl J Med. 2008;358:539–41.
Article
Google Scholar
Zhou J, Dudley ME, Rosenberg SA, Robbins PF. Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy. J Immunother. 2005;28:53.
Article
Google Scholar
Marcinkowski B, et al. Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1. J Immunother Cancer. 2019;7:1–9.
Article
Google Scholar
Howie B, et al. High-throughput pairing of T cell receptor α and β sequences. Sci Transl Med. 2015;7:301ra131.
Article
Google Scholar
Han A, Glanville J, Hansmann L, Davis MM. Linking T-cell receptor sequence to functional phenotype at the single-cell level. Nat Biotechnol. 2014;32:684–92.
Article
CAS
Google Scholar